Black Diamond Therapeutics Announces Financial Results and Strategic Updates for Q1 2025
May 12, 2025 - 22:08
In a recent corporate update, Black Diamond Therapeutics revealed significant advancements in its clinical trials and financial standing for the first quarter of 2025. The company is on track to present clinical data from its Phase 2 trial of BDTX-1535, targeting first-line patients with non-classical EGFR mutations in non-small cell lung cancer (NSCLC), with results expected in the fourth quarter of 2025.
Additionally, the company has initiated an expansion of its investigator-sponsored Phase 0/1 trial, focusing on newly diagnosed glioblastoma patients with EGFR alterations. This expansion commenced in the first quarter of 2025, reflecting the company’s commitment to exploring innovative treatment options for challenging cancers.
Financially, Black Diamond Therapeutics reported cash, cash equivalents, and investments totaling $152.4 million as of March 31, 2025. This financial position is anticipated to adequately support the company’s operations through to the fourth quarter of 2027, ensuring continued progress in its clinical and research endeavors.
MORE NEWS
April 7, 2026 - 00:24
Making Cents: Financial expert shares everyday habit to rethinkA leading financial expert is urging consumers to critically examine one of their most routine money habits: the use of digital payment apps and cards for daily, small purchases. While convenient,...
April 6, 2026 - 02:35
A Generational Investment Opportunity: 3 AI Stocks I'm Buying NowThe recent market volatility has created a compelling entry point for investors looking to build a position in the transformative field of artificial intelligence. Several industry-leading...
April 5, 2026 - 01:23
Isa savers under 65 have ‘last chance’ in the new 2026-27 tax yearThe approaching 2026-27 tax year represents a pivotal deadline for many UK savers. Individuals under the age of 65 are being alerted to a final chance to fully utilise the current annual Cash ISA...
April 4, 2026 - 17:14
Copper-Aluminum Divergence Unveils The Complex Iran War ImpactFour weeks into the ongoing Middle East conflict, a significant divergence has emerged between two key industrial metals: copper and aluminum. While both are sensitive to global economic sentiment,...